Physician

Afe Danielle Nkese Alexis, M.B.B.S., MSC

According to 2025 Medicare claims, Afe Alexis, M.B.B.S., MSC (NPI: 1215464565) practices pulmonary disease, with the plurality of this provider's patient population coming from Halifax, NC. This provider's primary affiliated billing organization is VIDANT MEDICAL GROUP LLC (NPI: 1477648731; TIN: 383740839) and primary practice location at 27870-4914. Alexis is affiliated with the Coastal Plains Network, LLC (ACO ID: A2684), participating under the MSSP model.

Alexis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 237 traditional Medicare patients, billed 1,164 HCPCS/CPT codes, and received $83,903 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 1,495 prescription claims across 215 beneficiaries totaling $347,032 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 52 claims. Open Payments data shows 39 records totaling $1,087. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,459 to $347,032. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	43	112	$8,199
2024	237	1,164	$83,903

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	11	$4,459
2019	N/R	45	$2,510
2020	N/R	N/R	N/R
2021	N/R	11	$395
2022	N/R	N/R	N/R
2023	31	64	$16,315
2024	215	1,495	$347,032

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	52	$851

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	68	200	$158
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	59	92	$96
99221	Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes	63	136	$61
94664	Evaluation of use of breathing device	64	113	$13
94729	Test to examine how well the lungs exchange gases	56	57	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	131	4,350	$92,928
Spiriva Respimat	Tiotropium Bromide	82	2,760	$47,023
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	68	2,040	$42,316
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	57	2,130	$33,345
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	62	1,860	$28,245

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	17	$440
E0570	Nebulizer, with compressor	Y	N/R	23	$231
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	N	N/R	12	$180

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	39	$1,087	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

Pulmonary disease providers
Providers within practice ZIP code 27870-4914
Providers whose plurality patient county is Halifax, NC
Providers in North Carolina whose primary affiliated billing organization is VIDANT MEDICAL GROUP LLC
Providers in North Carolina affiliated with Coastal Plains Network, LLC (MSSP)

FAQ

What Medicare data is available for Afe Danielle Nkese Alexis, M.B.B.S., MSC?

Tedicare shows public-source Medicare data for Afe Danielle Nkese Alexis, M.B.B.S., MSC (NPI 1215464565), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afe Danielle Nkese Alexis, M.B.B.S., MSC have ACO affiliation data?

Afe Danielle Nkese Alexis, M.B.B.S., MSC is shown with ACO affiliation data for Coastal Plains Network, LLC (MSSP, ACO ID A2684).

What billing organization is linked to Afe Danielle Nkese Alexis, M.B.B.S., MSC?

Afe Danielle Nkese Alexis, M.B.B.S., MSC is linked to VIDANT MEDICAL GROUP LLC (billing NPI 1477648731) in the available physician profile data.

Does Afe Danielle Nkese Alexis, M.B.B.S., MSC have Open Payments data?

Afe Danielle Nkese Alexis, M.B.B.S., MSC has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.